1. Home
  2. IFRX vs GAIA Comparison

IFRX vs GAIA Comparison

Compare IFRX & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$2.11

Market Cap

66.0M

Sector

Health Care

ML Signal

HOLD

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$3.27

Market Cap

70.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFRX
GAIA
Founded
2007
1988
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
66.0M
70.9M
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
IFRX
GAIA
Price
$2.11
$3.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$6.25
$6.50
AVG Volume (30 Days)
1.4M
53.9K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
N/A
N/A
Revenue
N/A
$4,500,000.00
Revenue This Year
N/A
$13.07
Revenue Next Year
N/A
$12.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.50
52 Week Low
$0.71
$2.45
52 Week High
$2.20
$6.39

Technical Indicators

Market Signals
Indicator
IFRX
GAIA
Relative Strength Index (RSI) 81.36 65.85
Support Level $0.86 $2.98
Resistance Level N/A $3.46
Average True Range (ATR) 0.22 0.13
MACD 0.07 0.05
Stochastic Oscillator 90.31 93.55

Price Performance

Historical Comparison
IFRX
GAIA

About IFRX InflaRx N.V.

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: